Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-02 to 2024-01-03
Current total value of award: $7509.64
Description: 4563214405!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML